ABCELLERA BIOLOGICS INC
ABCL · NASDAQ
Updated at 2026-10-14 10:03:30
- Today's High
- $12.72
- Today’s Low
- $12.20
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $12.71
- Previous Close
- $12.63
- Volume
- 5.75M
- Market Cap
- $4.09B
- P/E Ratio
- --
- EPS
- $-0.54
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Life Sciences Tools & Services
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 150 W 4TH AVENUE, VANCOUVER, BC, CANADA, V5Y 1G6
- Country
- CA
- Listing Date
- 2020-12-11
- Fiscal Year End
- December
- Shares Outstanding
- 305.38M
- CIK
- 0001703057
- Website
- www.abcellera.com
AbCellera Biologics Inc. develops an antibody discovery platform. The company is headquartered in Vancouver, Canada.
Financial Metrics
Revenue
2026-06-30
$4.05M
2026-03-31
$8.31M
2025-12-31
$44.85M
2025-09-30
$8.95M
Operating Expenses
2026-06-30
$66.82M
2026-03-31
$57.17M
2025-12-31
$65.51M
2025-09-30
$85.23M
Net Income
2026-06-30
-$55.42M
2026-03-31
-$43.16M
2025-12-31
-$8.94M
2025-09-30
-$57.11M
Net Profit Margin
2026-06-30
-1.36K%
2026-03-31
-519.12%
2025-12-31
-19.94%
2025-09-30
-637.84%
Earnings Per Share
2026-06-30
$-0.18
2026-03-31
$-0.14
2025-12-31
$-0.03
2025-09-30
$-0.19
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$50.18M
2026-03-31
-$40.88M
2025-12-31
-$11.57M
2025-09-30
-$66.31M
Effective Tax Rate
2026-06-30
6%
2026-03-31
12.86%
2025-12-31
54.12%
2025-09-30
16.93%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $4.05M | $8.31M | $44.85M | $8.95M |
| Operating Expenses | $66.82M | $57.17M | $65.51M | $85.23M |
| Net Income | -$55.42M | -$43.16M | -$8.94M | -$57.11M |
| Net Profit Margin | -1.36K% | -519.12% | -19.94% | -637.84% |
| Earnings Per Share | $-0.18 | $-0.14 | $-0.03 | $-0.19 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$50.18M | -$40.88M | -$11.57M | -$66.31M |
| Effective Tax Rate | 6% | 12.86% | 54.12% | 16.93% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.